Brand Name

Durezol

Generic Name
Difluprednate
View Brand Information
FDA approval date: January 25, 2011
Form: Emulsion

What is Durezol (Difluprednate)?

DUREZOL is a topical corticosteroid that is indicated for: The treatment of inflammation and pain associated with ocular surgery.

Approved To Treat

Top Global Experts

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

Zebrafish Functional Screening of FDA-Approved Drugs for Autosomal Dominant Retinitis Pigmentosa Caused by RHODOPSIN Q344X Mutation.
Zebrafish Functional Screening of FDA-Approved Drugs for Autosomal Dominant Retinitis Pigmentosa Caused by RHODOPSIN Q344X Mutation.
Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026
Preoperative Intravitreal Viscoelastic Injection (PIVOT) for Surgical Optimization in Rhegmatogenous Retinal Detachment With Choroidal Detachment.
Preoperative Intravitreal Viscoelastic Injection (PIVOT) for Surgical Optimization in Rhegmatogenous Retinal Detachment With Choroidal Detachment.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: April 22, 2026
Physicochemical characterisation of difluprednate and 6α9α-difluoroprednisolone: Determination of solubility, pKa and LogP.
Physicochemical characterisation of difluprednate and 6α9α-difluoroprednisolone: Determination of solubility, pKa and LogP.
Journal: Steroids
Published: January 29, 2026
View All Latest Advances